Pricing Log in Create free account
Saturday 17 October 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insulet Corporation (PODD) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Insulet Corporation (PODD) trades at a P/S ratio of 3.2×. Over the past ten years it has ranged from 3.0× (September 2026) to 21.1× (November 2021); the current reading is higher than 1% of that period. That is above the Medical Devices industry median of 2.3× and below the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 7.4× (16.39%)
FY2024 8.8× 2.76%
FY2023 8.6× (43.53%)
FY2022 15.2× (7.15%)
FY2021 16.4× (10.41%)
FY2020 18.3× 30.21%
FY2019 14.1× 69.70%
FY2018 8.3× (4.04%)
FY2017 8.6× 48.10%
FY2016 5.8× (28.39%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 3.5× (31.75%)
Mar 2026 5.1× (31.43%)
Dec 2025 7.4× (14.29%)
Sep 2025 8.6× (8.09%)
42 more quarters

Against its own ten years

Low 3.0× High 21.1×
Ten-year median 9.4×
Current reading's percentile 1

P/S ratio against peers

Company P/S ratio
SNN Smith & Nephew SNATS, Inc. compare 1.2×
BRKR Bruker Corporation compare 2.4×
PODD Insulet Corporation 3.2×
GMED Globus Medical, Inc. compare 3.3×
BIO Bio-Rad Laboratories, Inc. compare 3.7×
BIO.B Bio-Rad Laboratories, Inc. compare 3.8×
HAE Haemonetics Corporation compare 4.0×
PEN Penumbra, Inc. compare 8.4×
GKOS Glaukos Corporation compare 15.8×
Medical Devices industry median 2.3×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on PODD